Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Pieter Vermeersch and Jan Van Elslande.
Pieter Vermeersch
Connection Strength
4.413
Jan Van Elslande
  1. Estimated Half-Life of SARS-CoV-2 Anti-Spike Antibodies More Than Double the Half-Life of Anti-nucleocapsid Antibodies in Healthcare Workers. Clin Infect Dis. 2021 12 16; 73(12):2366-2368.
    View in: PubMed
    Score: 0.985
  2. Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. J Clin Virol. 2021 03; 136:104765.
    View in: PubMed
    Score: 0.930
  3. Immunoassays for anti-SARS-CoV-2 antibodies: recent insights. Lancet Infect Dis. 2021 05; 21(5):e120.
    View in: PubMed
    Score: 0.911
  4. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. Clin Microbiol Infect. 2020 Nov; 26(11):1557.e1-1557.e7.
    View in: PubMed
    Score: 0.895
  5. Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain. Clin Infect Dis. 2021 07 15; 73(2):354-356.
    View in: PubMed
    Score: 0.239
  6. Added value of anti-SARS-CoV-2 antibody testing in a Flemish nursing home during an acute COVID-19 outbreak in April 2020. Acta Clin Belg. 2020 Oct 18; 1-6.
    View in: PubMed
    Score: 0.227
  7. Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2. Clin Chem Lab Med. 2020 09 25; 58(10):e197-e199.
    View in: PubMed
    Score: 0.226
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.